Health Research Ethics Board of Alberta – List of Members

HREBA membership as of 21 May 2021.

 

Name Board TCPS 2 Roles & Specialties Sex City
Lauren Birks, PhD Cancer Committee Community Member (Population and Public Health) F Calgary
Ann Boerner, MN Clinical Trials Committee Community Member F Calgary
Ellen Burgess, MD Cancer Committee Scientific / Ethics (Nephrology / Pediatrics / Ethics) F Calgary
Karen Campbell, Cancer Committee Community Member F Edmonton
Susan Chafe, MD Cancer Committee Scientific (Pediatric Radiation Oncology / Law) F Edmonton
Brett Clelland, JD Community Health Committee (Vice-Chair) Law (Intellectual Property) M Edmonton
Cheryl Currie, PhD Clinical Trials Committee
Community Health Committee
Scientific (Quantitative / Qualitative methodology, including research involving Indigenous peoples and communities) F Lethbridge
Sambasivarao Damaraju, PhD Cancer Committee Scientific (Cancer Genetics / Pharmacogenetics / Precision Medicine) M Edmonton
Brenda Davis, LLM Cancer Committee Privacy / Law F Edmonton
Sunil Desai, MD Cancer Committee
Clinical Trials Committee (Vice Chair)
Scientific (Pediatric Hematology / Oncology) M Edmonton
Dale Dewhurst, LLM, JD Cancer Committee (Chair) Ethics / Law (Virtue Ethics / Access to Justice) M Edmonton
Allen Dong, P.Eng., MSc Cancer Committee Community Member (Data Stewardship) M Calgary
Katherine Duthie, PhD Cancer Committee Ethics (Clinical Ethics) F Edmonton
Alysa Fairchild, MD, FRCPC Cancer Committee Scientific (Radiation Oncology) F Edmonton
Carlos Flores-Mir, MD Clinical Trials Committee Scientific (Dental) M Edmonton
Sunita Ghosh, PhD Cancer Committee Scientific (Biostatistics) F Edmonton
Sarah Glaze, MD Cancer Committee Scientific (Medical Oncology) F Calgary
Allen Habib, PhD Community Health Committee Ethics (Philosophy) M Calgary
Desiree Hao, MD Cancer Committee Scientific (Medical Oncology) F Calgary
Joanne Hewitt, PhD Cancer Committee Scientific (Advanced Practice Nursing) F St. Albert
Eve Hildebrand, BA Cancer Committee Community Member F Edmonton
Lloyd Jamie Hodge, P.Eng. Community Health Committee Community Member M Calgary
Sandra Johansen, PhD Community Health Committee Scientific (Methodologist) F Calgary
Cyne Johnston, PhD Community Health Committee (Chair) Scientific (Qualitative / Mixed Methodology) F Calgary
Kimberley Kelly, MD Community Health Committee Scientific (Physian) F Edmonton
John Kennedy, MD, FRCPC Clinical Trials Committee Scientific (Psychiatry / Geriatrics / Neuropsychopharmacology) M Edmonton
Richard Lee-Ying, MD Cancer Committee Scientific (Medical Oncology) M Calgary
Elena Liew, MD Cancer Committee Scientific (Clinical Hematology) F Edmonton
Debbie Mallett Community Health Committee Community Member F Edmonton
Mary Marshall, LLM Cancer Committee Privacy / Law F Edmonton
Albert Mehl, MD Clinical Trials Committee Scientific (Pediatrics) M Black Diamond
Beverley O’Brien, PhD Cancer Committee Ethics (Nursing) F Edmonton
Jodi Parrotta, MA, CCRP Clinical Trials Committee Non-Scientific (Regulations) F Edmonton
Nimesh Patel, MPH Clinical Trials Committee
Community Health Committee
Scientific (Quantitative Methodology) M Lethbridge
Robert Pearcey, MD Cancer Committee Scientific (Radiation Oncology) M Edmonton
Guy Pelletier, PhD Cancer Committee Scientific (Psychosocial Oncology) M Calgary
Cheryl Pollard, RPN, RN, PhD, ANEF Clinical Trials Committee Scientific (Nursing) F Edmonton
Loralee Robertson, BSc,
MLT Dipl.
Clinical Trials Committee Community Member F Calgary
Gloria Roldán Urgoiti, MD, FRCPC Cancer Committee Scientific (Medical Oncology) F Calgary
Andrew Ross, PhD Clinical Trials Committee Ethics (Clinical Ethics) M Edmonton
Mary-Pat Schlosser, MD Cancer Committee Scientific (Pediatric Palliative Care) F Edmonton
Fiona Schulte, PhD Cancer Committee Scientific (Pediatric Psychosocial Oncology) F Calgary
Christopher Sikora, MD Community Health  Committee Scientific (Physician) M Edmonton
Michael Smylie, MD Cancer Committee Scientific (Medical Oncology) M Edmonton
Francine Swanson, BA LLB(H) Clinical Trials Committee Non-Scientific (Law) F Calgary
Keith Tankel, MD Cancer Committee Scientific (Radiation Oncology) M Edmonton
Andrew Robert Turner, MD Cancer Committee Scientific (Medical Oncology / Hematology) M Edmonton
Raul Urtasun, MD Cancer Committee (Vice Chair) Scientific (Radiation Oncology) M Edmonton
T. Edward Vant (Ted), MD Clinical Trials Committee Scientific (Family Medicine) M Calgary
Peter Venner, MD Cancer Committee (Vice Chair)
Clinical Trials Committee (Chair)
Scientific (Medical Oncology) M Edmonton
John Walker, MD Cancer Committee Scientific (Medical Oncology) M Edmonton
Brent Windwick, QC, LLM Cancer Committee
Clinical Trials Committee (Vice Chair)
Law (Health Law) M Edmonton
Jackson Wu, MD Cancer Committee (Vice Chair) Scientific (Radiation Oncology) M Calgary
Xiaofu Zhu, MD Cancer Committee Scientific (Medical Oncology) M Edmonton

 

The HIA-designated Health Research Ethics Board of Alberta consists of three committees [the Cancer Committee (CC), Clinical Trials Committee (CTC), and Community Health Committee (CHC)] operating as one Research Ethics Board. As such, members from one committee may attend another committee’s meeting when their expertise is required. This ensures that members in attendance have the specific expertise, relevant competence and knowledge necessary to provide an adequate research ethics review of the proposals under consideration.

The majority of the members are Canadian citizens or permanent residents under the Immigration and Refugee Protection Act.  HREBA is constituted and operates in accordance with the Alberta Health Information Act (HIA), the Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans (TCPS 2), Good Clinical Practice (GCP) Guidelines of the International Conference on Harmonization (ICH), Health Canada’s Food and Drug Regulations (FDR), Part C, Division 5 and is registered with the U.S. Department of Health and Human Services (HHS), Office for Human Research Protections (OHRP) where required.

Members named as Principal Investigators or Co-investigators on a study that is under review do not participate in discussions related to, nor vote on, such studies when they are presented; this applies to initial and continuing reviews.

A pdf version of this list, as well as previous lists of HREBA members, can be found here